Browse
Health Pages
Categories
Osteoporosis is one of the diseases for which women are regularly screened. However, lack of screening of men for osteoporosis has given rise to a major health concern with more men suffering from and at risk for osteoporosis than fathomable.

Due to the fact that osteoporosis is hailed as a women-only disease, men are never tested for osteoporosis. According to the statistics, almost 1 million men over the age of 65 succumb to osteoporosis in the United States. Almost 3.5 million men have been found to be at risk for osteoporosis. 

Women are diagnosed early on during the course of the disease due to regular screening programs and put on the road towards treatment. Men, on the other hand, do not undergo checkups and are therefore, far from receiving the treatment for osteoporosis. 
Family history is the primary risk factor for osteoporosis in men. Long-term steroid use, gut diseases, chemotherapy for prostate cancer and alcoholism are the other risk factors that play a major role in osteoporosis in men. 

A lot of causes can lead to osteoporosis in males including the use of immunosuppressant drugs, low testosterone levels, smoking, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, hyperthyroidism and various joint diseases etc. 


Annual Screening for Osteoporosis in Men 

The recent recommendations released by the American College of Physicians include annual screening for risk factors in men for osteoporosis when they cross the threshold of 50. The Endocrine Society has put forward the recommendation of starting regular bone density screening tests in men at the age of 70 as the risk of osteoporosis peaks at this age.

The key for optimal treatment of osteoporosis in men is timely diagnosis so that interventions can be started early. Only through annual screening tests, osteoporosis can be diagnosed during the initial stages and the risk of osteoporosis-related morbidity can be reduced. 

According to Mary Ruppe, M.D., an endocrinologist, almost 80,000 men suffer hip fractures every year due to reduction in their bone mineral density and the risk of death resulting from such fractures is even higher in men as compared to women. 

The statistics highlight the importance of heeding osteoporosis as a serious disease in men and the need to hold annual screenings for osteoporosis besides educating the masses about the importance of screening. 

Educating the male population about the threat of osteoporosis and to adopt active strategies to combat it is one of the major challenges since men fail to recognize osteoporosis as a threatening disease.

 It is imperative to advise men to quit smoking, avoid alcohol, increase the physical activity, ensure adequate daily intake of calcium and vitamin D and to avoid medications that may cause osteoporosis after talking to the doctors and weighing their potential benefits against the risks posed by them. 

The treatment strategies currently available for osteoporosis in men are the same as that in women. The medicines serve to maintain the bone density by regulating the bone formation process in order to prevent the risk of pathological fractures. 

Only though the diagnosis of osteoporosis in men in a timely fashion can early treatment be started and they can be tested for the underlying causes of the disease. Additional interventions like vitamin D supplementation and testosterone therapy can also be initiated in order to reduce the risk of morbidity and mortality associated with osteoporosis in men. 


Osteoporotic Women at Risk of Fractures despite Oral Bisphosphonates Use

 Bisphosphonates are the most commonly prescribed drugs for osteoporosis treatment in women. A recent study has revealed that the risk of osteoporotic fractures persists even after the use of oral bisphosphonates. 

Osteoporosis is a disease affecting nearly 53 million American women at or above the age of 50 years. Since the density of the bones is dramatically reduced in this disease, bone fractures are the most common complication associated with osteoporosis. 

Bisphosphonates are one the primary drugs given for osteoporosis and have been demonstrated to lower the risk of osteoporosis related fractures in women, if not completely eliminate it. Recent evidence suggests that the effectiveness of medications may be different when tested during trials than that of the clinical scenarios. 

A research was recently carried out by researchers under the supervision of Erik Imel, M.D., the Indiana University School of Medicine endocrinologist and Regenstrief Institute-affiliated scientist, through collaboration of Regenstrief Institute-Merck. The investigators were able to demonstrate that even after regular medication, most of the women carry the risk of osteoporosis-related fractures. 

During this cross-sectional retrospective study, the data of 7,435 women at or above the age of 50 was collected. The data, mainly figures about bone density and fractures, was collected from the Indiana Network for Patient Care and represented a wide scope of real-life clinical practices from a diverse background of patient and physician behaviors. These women had been on oral bisphosphonates for an interval of at least 2 years from 2000 to 2002. The results of the study were later published in the journal Bone. 


High Risk of Fractures Found In Women Taking Bisphosphonates 

According to Erik Imel, the lead researcher, it was found that most of the women who had been placed on oral bisphosphonates remained at high risk of hip, spine, and other fractures despite the fact that bisphosphonates strengthen the bones by increasing the bone density. Even then, bisphosphonates should remain a part of the first-line osteoporosis treatment regime. 

The study included only those women who were known to take bisphosphonates regularly. In women who were less compliant to their therapy, the efficacy of bisphosphonates was assumed to decline even further. According to the researchers, the efficacy of the drug can be enhanced only by adhering to the medication and through vigilance of both the doctor and the patient. 


How to Reduce the Risk of Fractures? 

This study has raised some serious questions like the advantages of prescribing bisphosphonates to osteoporotic women and what to do when the anticipated benefits of taking bisphosphonates fail to manifest. The scientists, however, do agree on the fact that the risk of fractures is significantly lower in women taking bisphosphonates as compared to those not using them. 

Since the study has effectively established that only sticking to the medications is not enough, other factors and lifestyle modifications should also be heeded in order to minimize the risk of falls and the resultant fractures. The various lifestyle modifications that can be easily adopted include the use of walking aids, smoking cessation, regular exercise and removal of the obstacles that may result in falls. 

This study has highlighted the importance of lifestyle changes in addition to taking medicines in order to reduce the obvious complication of fractures resulting from osteoporosis. 

Sources & Links

Post a comment